Graduate students whiz around this slimy beating heart and crawl under the tubes connected to the apparatus cradling the organ as a Medtronic scientist prods a snaking tool around its interior. This ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

In 2023, the catheter market is projected to surge to a size of around USD 12,591.30 million. In the forecast period from ...

Medtronic investors celebrated the announcement ... The analysis may lead to Medicare covering the catheter procedure by October, if not earlier. “Our Symplicity blood pressure procedure ...

Medtronic, which employs about 10,000 people in Minnesota, reported an adjusted net profit of $1.62 billion on $8.4 billion in sales for its second quarter, which ended Oct. 25.

CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

Milestone is supported by large public health need and robust, long-term data from the SPYRAL-HTN global clinical program GALWAY, Ireland, Jan. 13, 2025 /PRNewswire/ -- Medtronic plc (NYSE ...

Sanford Health is teaming up with Medtronic to test a procedure aimed at reducing medication dependency for high blood ...

Boston Scientific introduced 3 advanced balloon catheters in 2023 for lesion-specific treatment protocols in select Asia-Pacific markets. Medtronic reported developing 2 integrated balloon ...